onr:"swepub:oai:DiVA.org:uu-105292"
Search: onr:"swepub:oai:DiVA.org:uu-105292" > In vitro effect of ...
- 1 of 1
- Previous record
- Next record
- To hitlist
- Laytragoon-Lewin, NongnitUppsala universitet,Enheten för onkologi (author)
In vitro effect of radiation, antibody to epidermal growth factor receptor and Docetaxel in human head and neck squamous carcinoma cells with mutant P53 and over-expressed EGFR
- Article/chapterEnglish2009
Publisher, publication year, extent ...
- 2008-08-29
- Springer Science and Business Media LLC,2009
- printrdacarrier
Numbers
- LIBRIS-ID:oai:DiVA.org:uu-105292
- https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-105292URI
- https://doi.org/10.1007/s00432-008-0456-5DOI
- http://kipublications.ki.se/Default.aspx?queryparsed=id:118003454URI
Supplementary language notes
- Language:English
- Summary in:English
Part of subdatabase
- SwePubSwePub
Classification
Notes
- PURPOSE: Radiotherapy is the most frequently used and cheapest treatment both for curative and palliative purposes in HNSCC. Despite advances in technology and intensive treatments with radiation, only half of the patients are cured. New therapeutic approaches focusing on the molecular mechanism that mediate tumour cell growth or cell death in combination with radiotherapy have been suggested. The effects of radiation, antibody to EGFR and Docetaxel as single treatment or in combinations on HNSCC cells were investigated. METHODS: The established HNSCC cells with mutant (mt) P53 and over-expressed normal EGFR was used as the in vitro model. Gene expression profile, cell cycle progression and cell death were used as the indication of treatment outcome. RESULTS: With c-DNA microarray of well-characterised functional genes, massive changes in the genes expression of HNSCC were detected. The alterations of gene expression profiles do not have any correlation neither on tumour cell growth nor cell death. HNSCC cells with mt P53 and over-expressed normal EGFR did not response to radiation, anti-EGFR monoclonal antibody and their combination therapy. Effective treatment could be obtained from single therapy with Docetaxel. No additive effects on cell cycle arrest or cell death were seen in the combination of Docetaxel to anti-EGFR antibody, radiation or anti-EGFR antibody + radiation. CONCLUSIONS: The c-DNA microarray analysis does not indicate any specific target or treatment effects of HNSCC with mt P53 and over-expressed normal EGFR. Single therapy, target at microtubules might be the most suitable treatment modulation in this tumour type.
Subject headings and genre
- MEDICINE
- MEDICIN
Added entries (persons, corporate bodies, meetings, titles ...)
- Ustun, Hasan (author)
- Castro, Juan (author)
- Friesland, SigneKarolinska Institutet (author)
- Ghaderi, MehranKarolinska Institutet (author)
- Lundgren, Jan (author)
- Turesson, IngelaUppsala universitet,Enheten för onkologi,Turesson, I(Swepub:uu)ingeture (author)
- Lewin, Freddi (author)
- Uppsala universitetEnheten för onkologi (creator_code:org_t)
Related titles
- In:Journal of Cancer Research and Clinical Oncology: Springer Science and Business Media LLC135:2, s. 203-90171-52161432-1335
Internet link
Find in a library
- Journal of Cancer Research and Clinical Oncology (Search for host publication in LIBRIS)
To the university's database
- 1 of 1
- Previous record
- Next record
- To hitlist
Find more in SwePub
- By the author/editor
- Laytragoon-Lewin ...
- Ustun, Hasan
- Castro, Juan
- Friesland, Signe
- Ghaderi, Mehran
- Lundgren, Jan
- show more...
- Turesson, Ingela
- Lewin, Freddi
- show less...
- Articles in the publication
- Journal of Cance ...
- By the university
- Uppsala University
- Karolinska Institutet
Search outside SwePub
- Extend your search to:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - National Library Systems
- LIBRIS.kb.se
